IPC raises concern over five lifesaving drugs for causing adverse reaction

[ad_1] New Delhi: The Indian Pharmacopoeia Commission (IPC), a body under the health ministry, has named five lifesaving drugs as having shown serious side effects. The drugs are Metronidazole, an antibiotic; Luliconazole, an antifungal; Dalteparin, used for cancer treatment; diabetics drug Gliclazide and Tramadol, a painkiller. During a recently conducted analysis of adverse drug reactions…

Read More

Should cancer be a notifiable disease?

[ad_1] Department of Medical Oncology at Nizam’s Institute of Medical Sciences (NIMS), Hyderabad organised an awareness walk to promote cancer prevention making ‘World Cancer Day’ on Tuesday, February 4, 2025. | Photo Credit: RAMAKRISHNA G Time and again, there have been calls to designate cancer as a notifiable disease in India. While some argue that…

Read More

Sun Pharma to acquire Nasdaq-listed Checkpoint Therapeutics for $355 million; shares edge higher

[ad_1] Sun Pharmaceutical Industries Ltd. has announced the acquisition of Nasdaq-listed Checkpoint Therapeutics, Inc., an immunotherapy and targeted oncology company, in a $355 million cash deal. The acquisition will bolster Sun Pharma’s onco-dermatology portfolio, adding Checkpoint’s recently FDA-approved cancer drug, UNLOXCYT (cosibelimab-ipdl), to its pipeline. The deal, expected to close in the second quarter of…

Read More

Cancer was fastest-growing ailment in 2024: Medi Assist report

[ad_1] Cancer was the fastest-growing ailment in India in 2024, while respiratory illnesses saw the highest increase in the average cost of treatment, a report released by health benefits administrator Medi Assist said on Thursday. Cancer incidence rates—the percentage of claims with respect to overall people insured—grew 10-12% year-on-year in 2024, according to the report….

Read More
Back To Top